Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.65B | 10.16B | 11.00B | 11.29B | 9.38B | Gross Profit |
1.91B | 3.08B | 3.06B | 2.81B | 2.57B | EBIT |
321.83M | 1.62B | 1.63B | 1.14B | 754.28M | EBITDA |
354.00M | 1.64B | 1.65B | 1.18B | 794.88M | Net Income Common Stockholders |
341.11M | 1.26B | 1.26B | 880.01M | 580.72M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.35B | 5.64B | 6.18B | 6.52B | 5.00B | Total Assets |
17.02B | 14.68B | 15.48B | 17.42B | 20.86B | Total Debt |
5.12B | 3.03B | 4.31B | 7.33B | 11.88B | Net Debt |
-228.72M | -2.61B | -1.87B | 805.45M | 6.88B | Total Liabilities |
6.76B | 4.39B | 6.08B | 9.03B | 13.20B | Stockholders Equity |
10.21B | 10.23B | 9.34B | 8.33B | 7.60B |
Cash Flow | Free Cash Flow | |||
-1.99B | 1.13B | 2.94B | 6.22B | -2.06B | Operating Cash Flow |
-1.14B | 1.22B | 2.95B | 6.23B | -2.05B | Investing Cash Flow |
-842.87M | 897.42M | -497.27M | -2.46M | -373.87M | Financing Cash Flow |
1.72B | -1.65B | -3.28B | -4.71B | 3.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥2.62B | 11.06 | 3.64% | -31.48% | -60.03% | ||
75 Outperform | ¥5.89B | 4.45 | 2.83% | 6.51% | 83.03% | ||
73 Outperform | ¥7.70B | 3.98 | 1.57% | -0.58% | 1546.93% | ||
70 Outperform | ¥12.68B | 12.76 | 2.56% | 5.06% | -39.19% | ||
63 Neutral | ¥6.52B | 27.11 | 3.74% | -21.68% | -77.48% | ||
61 Neutral | $2.83B | 10.72 | 0.40% | 6.10% | 5.80% | -21.26% | |
40 Underperform | ¥3.86B | ― | 1.17% | 47.01% | 98.52% |